HPV HR Testing – Early Detection of Cervical Cancer Risk | Protecting Women’s Health скачать в хорошем качестве

HPV HR Testing – Early Detection of Cervical Cancer Risk | Protecting Women’s Health

HPV HR (High-Risk Human Papillomavirus) testing is a vital tool in the early detection and prevention of cervical cancer — one of the leading causes of cancer-related deaths in women worldwide. This advanced diagnostic test detects high-risk strains of HPV known to cause over 99% of cervical cancer cases. By identifying the virus before it causes cell changes, HPV HR testing empowers early intervention and saves lives. Key Highlights: Detects high-risk HPV genotypes (like 16, 18, and others) Highly sensitive and accurate molecular testing Suitable for women aged 30 and above Can be done with or without Pap smear Ideal for population-level screening and individual care ✅ Non-invasive ✅ Fast turnaround time ✅ Crucial for cervical cancer screening programs When combined with Truenat's rapid molecular platform, HPV HR testing becomes accessible even in low-resource settings, enabling wider reach and earlier care. Early detection is the best protection. Prioritize women’s health with regular HPV HR screening. #HPVHR #CervicalCancerAwareness #WomensHealth #HPVTesting #CancerPrevention #MolecularDiagnostics #Truenat #ScreeningSavesLives #HealthInnovation #MadeInIndia